Opinion|Videos|May 29, 2024
Unmet Needs in Relapsed or Refractory Multiple Myeloma
Sarah Rockwell, PharmD, BCOP, and Ke Ning, MD, share their concluding remarks, reflecting on the current landscape and expressing their aspirations for addressing remaining unmet needs.
Advertisement
Episodes in this series
Advertisement
Related to this article
Persistent symptoms can complicate life after a multiple myeloma treatment response, making routine symptom assessment and targeted supportive care essential.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
4
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
5